Chemoinformaics analysis of Dl-Lactic-Acid
| Molecular Weight | 90.078 | nRot | 1 |
| Heavy Atom Molecular Weight | 84.03 | nRig | 1 |
| Exact Molecular Weight | 90.0317 | nRing | 0 |
| Solubility: LogS | 0.395 | nHRing | 0 |
| Solubility: LogP | -1.047 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 11.4168 |
| nHD | 2 | BPOL | 6.88724 |
| QED | 0.401 |
| Synth | 2.478 |
| Natural Product Likeliness | 0.614 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.539 |
| HIA | 0.008 |
| CACO-2 | -4.931 |
| MDCK | 0.00352008 |
| BBB | 0.229 |
| PPB | 0.126666 |
| VDSS | 0.703 |
| FU | 0.841271 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.248 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.503 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.191 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.224 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.061 |
| CL | 2.497 |
| T12 | 0.88 |
| hERG | 0.012 |
| Ames | 0.307 |
| ROA | 0.07 |
| SkinSen | 0.783 |
| Carcinogencity | 0.107 |
| EI | 0.994 |
| Respiratory | 0.103 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.958183 |